Quick Takeaways
- Joshua Reed has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $950,840.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Joshua Reed and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics, Inc. | Chief Financial Officer | $478,196 | 30 Mar 2022 | ||
| SRRK | Scholar Rock Holding Corp | Director | $472,644 | -$160,463 | -25% | 29 May 2025 |
| ALKS | Alkermes plc. | SVP, Chief Financial Officer | 02 Mar 2026 | |||
| OMGA | Omega Therapeutics, Inc. | Chief Financial Officer | 07 Feb 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|